Clinical Trial Update: An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial of pregabalin in subjects with refractory partial seizures was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsy | Phase 3 | Status: TERMINATED | Results posted: 2012-10-23